Table 2.
Contribution of diagnostic techniques according to final diagnosis and type of specimen in intraocular lymphomas.
| Patient | Final diagnosis | Sample | Pathological diagnosis | IHC contributory | FC contributory |
|---|---|---|---|---|---|
| 1 | PIOL T | Vitreous | Suspicious | No | NP |
| 2 | PIOL DLBCL | Vitreous | Lymphoma | NP | NP |
| 3 | PIOL DLBCL | Vitreous | Lymphoma | Yes | No |
| 3 | PIOL DLBCL | Vitreous | Lymphoma | Yes | NP |
| 4 | PIOL DLBCL | Aqueous | Lymphoma | Yes | Yes |
| 5 | PIOL DLBCL | Vitreous | Lymphoma | Yes | NP |
| 6 | PIOL DLBCL | Vitreous | Lymphoma | Yes | NP |
| 7 | PIOL DLBCL | Enucleation | Lymphoma | Yes | NP |
| 8 | PIOL DLBCL | Vitreous | Lymphoma | Yes | NP |
| 8 | PIOL DLBCL | Vitreous | Lymphoma | Yes | Yes |
| 9 | PIOL DLBCL | Vitreous | Lymphoma | Yes | Yes |
| 10 | SIOL T-NK | Vitreous | Lymphoma | Yes | Yes |
| 11 | SIOL DLBCL | Vitreous | Negative | NP | NP |
| 11 | SIOL DLBCL | Subretinal aspirate | Lymphoma | Yes | NP |
| 11 | SIOL DLBCL | Retinal biopsy | Lymphoma | Yes | NP |
| 12 | SIOL DLBCL | Aqueous | Suspicious | Yes | NP |
| 13 | SIOL DLBCL | Vitreous | Negative | NP | No |
| 13 | SIOL DLBCL | Vitreous | Lymphoma | Yes | Yes |
| 14 | SIOL DLBCL | Vitreous | Lymphoma | Yes | Yes |
| 15 | SIOL DLBCL | Vitreous | Suspicious | No | No |
| 15 | SIOL DLBCL | Retinal biopsy | Lymphoma | Yes | NP |
| 16 | PIOL MALT B | Teno-Conjuntival biopsy | Lymphoma | Yes | NP |
| 17 | PIOL MALT B | Teno-Conjuntival biopsy | Lymphoma | Yes | No |
| 18 | PIOL MALT B | Iris biopsy | Lymphoma | Yes | Yes |
| 19 | PIOL MALT B | Teno-Conjuntival biopsy | Lymphoma | Yes | NP |
PIOL, primary intraocular lymphoma; SIOL, secondary intraocular lymphoma; DLBCL, diffuse large B-cell lymphoma; NK, natural killer; MALT B, mucosa-associated lymphoid tissue B-cell lymphoma; IHC, inmunohistochemistry; FC, flow cytometry; NP, not performed.